GB9922462D0 - The use of triazolo-pyridazine derivatives for treating hearing loss - Google Patents

The use of triazolo-pyridazine derivatives for treating hearing loss

Info

Publication number
GB9922462D0
GB9922462D0 GBGB9922462.8A GB9922462A GB9922462D0 GB 9922462 D0 GB9922462 D0 GB 9922462D0 GB 9922462 A GB9922462 A GB 9922462A GB 9922462 D0 GB9922462 D0 GB 9922462D0
Authority
GB
United Kingdom
Prior art keywords
triazolo
hearing loss
pyridazine derivatives
treating hearing
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9922462.8A
Other versions
GB2342043A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Publication of GB9922462D0 publication Critical patent/GB9922462D0/en
Publication of GB2342043A publication Critical patent/GB2342043A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9922462A 1998-09-30 1999-09-22 The use of triazolo-pyridazine derivatives in the treatment of hearing loss and tinnitus Withdrawn GB2342043A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9821179.0A GB9821179D0 (en) 1998-09-30 1998-09-30 Therapeutic use

Publications (2)

Publication Number Publication Date
GB9922462D0 true GB9922462D0 (en) 1999-11-24
GB2342043A GB2342043A (en) 2000-04-05

Family

ID=10839667

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9821179.0A Ceased GB9821179D0 (en) 1998-09-30 1998-09-30 Therapeutic use
GB9922462A Withdrawn GB2342043A (en) 1998-09-30 1999-09-22 The use of triazolo-pyridazine derivatives in the treatment of hearing loss and tinnitus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB9821179.0A Ceased GB9821179D0 (en) 1998-09-30 1998-09-30 Therapeutic use

Country Status (1)

Country Link
GB (2) GB9821179D0 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2474000A1 (en) * 2002-01-31 2003-08-07 Warner-Lambert Company Llc Alpha 2 delta ligands to treat tinnitus
KR20060032633A (en) 2003-07-11 2006-04-17 엘비온 아게 Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8703749D0 (en) * 1987-02-18 1987-03-25 Sandoz Ltd Piperazinecarboxylic acid
TW450807B (en) * 1995-09-15 2001-08-21 Pfizer Pharmaceutical compositions for treating tinnitus comprising neuroprotective agents
DK0784973T3 (en) * 1995-10-10 2002-03-18 Pfizer Quinoxaline derivatives for the treatment of tinnitus
US6255305B1 (en) * 1996-07-25 2001-07-03 Merck Sharp & Dohme Limited Substituted triazolo-pyridazine derivatives as ligands for GABA receptors
WO1999043677A1 (en) * 1998-02-25 1999-09-02 Merck Sharp & Dohme Limited SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PYRIDAZINE
GB9805559D0 (en) * 1998-03-16 1998-05-13 Merck Sharp & Dohme A combination of therapeutic agents

Also Published As

Publication number Publication date
GB9821179D0 (en) 1998-11-25
GB2342043A (en) 2000-04-05

Similar Documents

Publication Publication Date Title
SG74725A1 (en) Disposale diaper
GB9824436D0 (en) Methods of treatment
HK1150756A1 (en) Antibiotic compositions for treatment of the ear
AU1772399A (en) Well treatment
HK1041827B (en) Compounds for the treatment of estrogen-defendent illnesses and methods for making and using the same
AU142196S (en) Tissue
AU5038299A (en) Process for the biocidal treatment of surfaces
HUP0200738A3 (en) Method of the treatment of incontinence
AU5056099A (en) Compounds for use in the treatment of inflammation
AU1697197A (en) Immunoconjugate for the treatment of aids
HK1042847A1 (en) Bone-pathobolism treating agent
AU8451298A (en) Treatment of fabrics
HUP0101947A3 (en) Combination for the treatment of tumors
AU3814599A (en) Use of erythropoietin for the treatment of haemochromatoses
AU9278598A (en) Use of azole derivatives for the treatment of inflammatory skin conditions
GB9922462D0 (en) The use of triazolo-pyridazine derivatives for treating hearing loss
HUP0100365A3 (en) Combination therapy for the treatment of aids
AU142195S (en) Tissue
IL137439A0 (en) Method for the determination of prosthetic infections
AU2619199A (en) Treatment of waxes
AU5524399A (en) Inorgasmia treatment
GB9815497D0 (en) Treatment
AU142197S (en) Tissue
SI1068184T1 (en) N-aryloxyethylamine derivatives for the treatment of depression
AU2574699A (en) Use of extracts from aristolochia in the treatment of aids

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)